Home › Research › Long-term cohort studies
Serum magnesium is associated with the risk of dementia
Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, Stricker BH, Ikram MA.. Neurology, 2017-09-20
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To determine if serum magnesium levels are associated with the risk of all-cause dementia and Alzheimer disease. Methods Within the prospective population-based Rotterdam Study, we measured serum magnesium levels in 9,569 participants, free from dementia at baseline (1997-2008). Participants were subsequently followed up for incident dementia, determined according to the DSM-III-R criteria, until January 1, 2015.
What this study adds
Evidence grade: Moderate
The record lists 9,569 participants. This study found that serum magnesium levels were associated with the risk of all-cause dementia and Alzheimer disease in a large population followed for years. Reported effect size: 56.6%; HR 1.30.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kieboom, B. C. T., Licher, S., Wolters, F. J., Ikram, M. K., Hoorn, E. J., Zietse, R., et al. (2017). Serum magnesium is associated with the risk of dementia. Neurology. https://doi.org/10.1212/wnl.0000000000004517
Vancouver
Kieboom BCT, Licher S, Wolters FJ, Ikram MK, Hoorn EJ, Zietse R, et al. Serum magnesium is associated with the risk of dementia. Neurology. 2017. doi:10.1212/wnl.0000000000004517. PMID: 28931641.
BibTeX
@article{kieboom2017-28931641,
author = {Kieboom, B. C. T. and Licher, S. and Wolters, F. J. and Ikram, M. K. and Hoorn, E. J. and Zietse, R. and Stricker, B. H. and Ikram, M. A.},
title = {{Serum magnesium is associated with the risk of dementia}},
journal = {Neurology},
year = {2017},
doi = {10.1212/wnl.0000000000004517},
pmid = {28931641},
url = {https://doi.org/10.1212/wnl.0000000000004517}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Methods Within the prospective population-based Rotterdam Study, we measured serum magnesium levels in 9,569 participants, free from dementia at baseline (1997-2008).
- Participants were subsequently followed up for incident dementia, determined according to the DSM-III-R criteria, until January 1, 2015.
- We used Cox proportional hazard regression models to associate quintiles of serum magnesium with incident all-cause dementia.
- We used the third quintile as a reference group and adjusted for age, sex, Rotterdam Study cohort, educational level, cardiovascular risk factors, kidney function, comorbidities, other electrolytes, and diuretic use.
Why it matters
This study found that serum magnesium levels were associated with the risk of all-cause dementia and Alzheimer disease in a large population followed for years. It does not show that changing magnesium levels prevents or treats dementia, only that a link exists.
Study details
- Participants9,569
- Effect size56.6%; HR 1.30
- Evidence strengthModerate
How this study scored 55/100
Published in a leading specialty journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 9,569 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 66 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.0 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 3 / 6 | Cited 3.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 26 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author M. Arfan Ikram: h-index 167 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28931641) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.